Salvia Bioelectronics

Salvia BioElectronics is pioneering a breakthrough therapy to transform chronic migraine treatment. MySalvia Therapy features an ultra-thin, unnoticeable implant designed to calm key nerves involved in migraine, activated with a simple tap on a small wearable device. Built for everyday life, it is developed to deliver drug-free relief without compromise. So, millions of people with migraine can live life, uninterrupted. Founded in 2017 in Europe’s tech capital Eindhoven, Salvia brings together skilled device makers and MedTech entrepreneurs with extensive experience in medical devices and neuromodulation. Active in the United States, Europe, and Australia, the company is advancing clinical development with the support of leading investors. Salvia is also exploring the potential of its innovative technology for the treatment of cluster headache.